UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

November 14, 2013

 

ALLIED HEALTHCARE PRODUCTS, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware   0-19266   25-1370721
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

 

1720 Sublette Avenue, St. Louis, Missouri   63110
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code

(314) 771-2400

 

Not applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 14, 2013. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934. There was no solicitation in opposition to management’s nominees for Directors. The voting results are noted below.

 

ELECTION OF DIRECTORS

 

All nominees for Directors were elected with the following votes cast:

 

     For     Withheld     Broker Non-Votes 
                   
Judith T. Graves   6,335,351    16,401    1,166,405 
Joseph E. Root   6,334,526    17,226    1,166,405 
William A. Peck   6,331,882    19,870    1,166,405 
Earl R. Refsland   6,331,948    19,805    1,166,405 
John D. Weil   6,306,245    45,507    1,166,405 

 

Agenda Item 2, concerning the ratification of the appointment of RubinBrown LLP as the Company’s independent registered public accounting firm for fiscal 2014 was approved by the stockholders with the following votes cast:

 

  For     Against     Abstain     Broker Non-Votes 
 7,498,357    14,819    4,982    0 

 

Agenda Item 3, an advisory (non-binding) vote to approve our executive compensation was approved by the stockholders with the following votes cast:

 

  For     Against     Abstain     Broker Non-Votes 
 6,317,757    19,679    14,316    1,166,405 

 

Agenda Item 4, an advisory (non-binding) vote on the frequency of the advisory vote on executive compensation, had the following votes cast by the stockholders:

 

  1 Year     2 Years     3 Years     Abstain 
 6,323,188    6,353    21,333    878 

 

In light of the voting results with respect to this proposal, the Company has decided to hold a shareholder advisory vote every year to approve the compensation of the Company’s named executive officers until the next advisory vote on the frequency of shareholder votes on executive compensation, which will occur no later than our Annual Meeting in 2019.

 

 
 

 

Agenda Item 5, concerning the approval of the Company’s 2013 Incentive Stock Plan for Non-Employee Directors was approved by the stockholders with the following votes cast:

 

  For     Against     Abstain     Broker Non-Votes 
 6,329,302    21,941    510    1,166,405 

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ALLIED HEALTHCARE PRODUCTS, INC.
     
  By:  
Date:  November 14, 2013   /s/  Daniel C. Dunn
      Daniel C. Dunn
      Chief Financial Officer